tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY

Incyte (INCY) Similar Stocks

Compare
1,710 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$59.16
$11.45B
218.14
14.47%
6 Buy
11 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$63.30
$12.14B
28.78
-21.76%
16 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$37.43
$10.32B
21.12
57.93%
9 Buy
6 Hold
0 Sell
Moderate Buy
United Therapeutics
$291.38
$13.09B
11.85
24.60%
7 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$164.15
$9.82B
20.79%
12 Buy
1 Hold
0 Sell
Strong Buy
Genmab
$20.59
$12.60B
11.63
-26.86%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
59.16
6.60
12.56%
BMRN
BioMarin Pharmaceutical
63.30
-18.83
-22.93%
EXEL
Exelixis
37.43
13.70
57.73%
UTHR
United Therapeutics
291.38
53.12
22.29%
ASND
Ascendis Pharma
164.15
24.00
17.12%
GMAB
Genmab
20.59
-7.98
-27.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis